- Serum alkaline phosphatase (ALP) exists in different isoenzyme forms that originate from various tissues like liver, bone and leukocytes. Measuring specific isoenzymes can help identify abnormal increases of total ALP and determine their tissue of origin.
- Neutrophil alkaline phosphatase (NAP) is an isoenzyme found in leukocytes. Abnormal NAP levels can indicate various inflammatory conditions and cancers. Semi-quantitative assays are used to measure NAP in serum.
- Differentiating between liver-derived ALP, bone ALP and other isoenzymes is important for correctly diagnosing diseases affecting those tissues that cause high total ALP levels, such as liver disease
The document discusses various laboratory tests used to evaluate liver function and disease. It describes tests for hepatocellular damage like ALT and AST, tests for cholestasis like alkaline phosphatase, and tests for liver synthetic function like albumin. Common causes of abnormal liver enzymes are also summarized, along with risk factors for liver disease.
ROLE OF LIVER ENZYMES IN DIAGNOSTIC PATHOLOGYAnkita Sain
This document provides an overview of the role of liver enzymes in diagnostic pathology. It discusses the following key points in 3 sentences:
Liver enzymes are released into blood when liver cells are damaged and can indicate conditions affecting the liver such as viral hepatitis, alcohol damage, cirrhosis, and cancer. Common liver enzymes measured include ALT, AST, ALP, GGT, and LDH, which are elevated in different conditions and patterns depending on the type and location of liver injury. Interpretation of liver enzyme levels along with other clinical information can help diagnose liver diseases, monitor treatment response, and provide prognostic information.
ALT is an enzyme present in liver, heart skeletal muscles, highest concentration is present in Liver. it value increases when there is abnormality in liver, ALT is an amino transferase which transfer one amino group from an amino acid and transfer to another substance for production of non essential amino acid
Alkaline phosphatase (ALP) activity and location were examined in the earthworm Lumbricus terristris. Histochemical staining showed high ALP levels in the intestine and crop/gizzard tissues. Enzyme assays found these tissues also had the highest ALP activity. While ALP activity varied with pH, temperature, and cofactors in L. terristris, the properties differed from mammalian ALP, suggesting earthworms may not be a good model for further research.
Alanine aminotransferase (ALT) is an enzyme found primarily in the liver and kidney that was originally referred to as serum glutamic pyruvic transaminase (SGPT). ALT levels are normally low in the serum but increase with liver damage and are used to screen for and monitor liver disease. The ALT test works by measuring the conversion of L-alanine and α-ketoglutarate to pyruvate and glutamate by SGPT, and then measuring the intensity of the brown colored complex formed between pyruvate and 2,4-dinitrophenyl hydrazine. Elevated ALT can indicate liver damage from viral hepatitis, toxins, drugs, tumors, or chronic liver
The document describes the procedure for measuring alkaline phosphatase (ALP) activity in serum. There are two types of phosphatases: alkaline phosphatase, which has maximum activity at pH 10, and acid phosphatase, which has maximum activity between pH 5-6. The ALP assay involves using phenylphosphate as the substrate, which is broken down by ALP to produce phenol. The phenol then reacts with 4-aminoantipyrine and potassium ferricyanide to form a colored complex, which is measured spectrophotometrically. Normal ALP ranges from 21-92 IU/L or 3-13 KA units. Elevated levels can indicate bone, liver or other diseases.
A 22-year-old male presented with jaundice, fatigue, and muscle pain for 6 months. Liver tests showed elevated bilirubin, AST, and prolonged PT/INR, suggesting a chronic liver disease. A 19-year-old female with history of chicken pox 8 months ago developed jaundice. Liver tests showed direct hyperbilirubinemia, elevated AST and markedly elevated ALP, indicating a cholestatic picture with ongoing activity. A 32-year-old alcoholic male with known cirrhosis showed mild elevation of AST and direct hyperbilirubinemia, with AST/ALT ratio of 3:1, consistent with alcoholic liver disease with ongoing activity.
The document discusses aminotransferases, which are enzymes found mainly in the liver that help catalyze reactions between amino acids and alpha-keto acids. Aminotransferases are important for synthesizing amino acids and proteins. They are also clinically significant as indicators of liver damage. Specifically, elevated levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in the blood can signify liver injury. The document outlines normal AST and ALT levels and various diseases and conditions that can cause their elevation, including viral hepatitis, alcohol abuse, and certain medications. It recommends further evaluation and treatment of any underlying cause if AST and ALT levels are found to be high.
The document discusses various laboratory tests used to evaluate liver function and disease. It describes tests for hepatocellular damage like ALT and AST, tests for cholestasis like alkaline phosphatase, and tests for liver synthetic function like albumin. Common causes of abnormal liver enzymes are also summarized, along with risk factors for liver disease.
ROLE OF LIVER ENZYMES IN DIAGNOSTIC PATHOLOGYAnkita Sain
This document provides an overview of the role of liver enzymes in diagnostic pathology. It discusses the following key points in 3 sentences:
Liver enzymes are released into blood when liver cells are damaged and can indicate conditions affecting the liver such as viral hepatitis, alcohol damage, cirrhosis, and cancer. Common liver enzymes measured include ALT, AST, ALP, GGT, and LDH, which are elevated in different conditions and patterns depending on the type and location of liver injury. Interpretation of liver enzyme levels along with other clinical information can help diagnose liver diseases, monitor treatment response, and provide prognostic information.
ALT is an enzyme present in liver, heart skeletal muscles, highest concentration is present in Liver. it value increases when there is abnormality in liver, ALT is an amino transferase which transfer one amino group from an amino acid and transfer to another substance for production of non essential amino acid
Alkaline phosphatase (ALP) activity and location were examined in the earthworm Lumbricus terristris. Histochemical staining showed high ALP levels in the intestine and crop/gizzard tissues. Enzyme assays found these tissues also had the highest ALP activity. While ALP activity varied with pH, temperature, and cofactors in L. terristris, the properties differed from mammalian ALP, suggesting earthworms may not be a good model for further research.
Alanine aminotransferase (ALT) is an enzyme found primarily in the liver and kidney that was originally referred to as serum glutamic pyruvic transaminase (SGPT). ALT levels are normally low in the serum but increase with liver damage and are used to screen for and monitor liver disease. The ALT test works by measuring the conversion of L-alanine and α-ketoglutarate to pyruvate and glutamate by SGPT, and then measuring the intensity of the brown colored complex formed between pyruvate and 2,4-dinitrophenyl hydrazine. Elevated ALT can indicate liver damage from viral hepatitis, toxins, drugs, tumors, or chronic liver
The document describes the procedure for measuring alkaline phosphatase (ALP) activity in serum. There are two types of phosphatases: alkaline phosphatase, which has maximum activity at pH 10, and acid phosphatase, which has maximum activity between pH 5-6. The ALP assay involves using phenylphosphate as the substrate, which is broken down by ALP to produce phenol. The phenol then reacts with 4-aminoantipyrine and potassium ferricyanide to form a colored complex, which is measured spectrophotometrically. Normal ALP ranges from 21-92 IU/L or 3-13 KA units. Elevated levels can indicate bone, liver or other diseases.
A 22-year-old male presented with jaundice, fatigue, and muscle pain for 6 months. Liver tests showed elevated bilirubin, AST, and prolonged PT/INR, suggesting a chronic liver disease. A 19-year-old female with history of chicken pox 8 months ago developed jaundice. Liver tests showed direct hyperbilirubinemia, elevated AST and markedly elevated ALP, indicating a cholestatic picture with ongoing activity. A 32-year-old alcoholic male with known cirrhosis showed mild elevation of AST and direct hyperbilirubinemia, with AST/ALT ratio of 3:1, consistent with alcoholic liver disease with ongoing activity.
The document discusses aminotransferases, which are enzymes found mainly in the liver that help catalyze reactions between amino acids and alpha-keto acids. Aminotransferases are important for synthesizing amino acids and proteins. They are also clinically significant as indicators of liver damage. Specifically, elevated levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in the blood can signify liver injury. The document outlines normal AST and ALT levels and various diseases and conditions that can cause their elevation, including viral hepatitis, alcohol abuse, and certain medications. It recommends further evaluation and treatment of any underlying cause if AST and ALT levels are found to be high.
This document summarizes key details about aminotransferases and alkaline phosphatase enzymes. It discusses how aminotransferases like aspartate aminotransferase (AST) and alanine aminotransferase (ALT) catalyze the transfer of amino groups between amino acids and ketoacids, and how their levels are measured to monitor liver damage. AST is more elevated in conditions like hepatitis while ALT is higher in viral hepatitis. Alkaline phosphatase requires magnesium as an activator and exists as isoenzymes in the liver, bone, placenta and intestine that can be differentiated through electrophoresis or immunochemical methods.
Biochemical markers in diagnosis of Liver DIseaseChee Oh
This document discusses liver enzyme tests, what they measure, normal ranges, and their clinical significance in evaluating liver health and disease. It focuses on aminotransferases ALT and AST, which are released when liver cells are damaged and are markers of hepatocellular injury. Elevations in ALT are more specific to the liver, while AST is also found in other tissues. The ratio of AST to ALT and the magnitude of elevation provides clues to different liver diseases.
1. A 65-year-old male presented with fever, abdominal pain, distension, and jaundice for 4 weeks. Imaging showed a diffuse process in the liver. Liver biopsy revealed adenocarcinoma infiltration of the liver.
2. A 58-year-old female with diabetes and elevated liver enzymes was evaluated. She had a history of elevated enzymes attributed to lipid medication years ago. Current labs showed elevated AST and ALT with normal ALP and GGT. She had weight gain and abnormal lipid profile.
3. The first case describes a patient with diffuse liver lesions found to be metastatic adenocarcinoma on biopsy. The second case involves a patient with metabolic risk factors and elevated amin
1. The document discusses alanine aminotransferase (ALAT/ALT), an enzyme that plays important roles in amino acid and carbohydrate metabolism.
2. ALT catalyzes the reversible transfer of amino groups between glutamate and pyruvate, and is important for liver gluconeogenesis and the glucose-alanine cycle.
3. Clinically, ALT levels are measured as a biomarker for liver health, with elevated levels indicating potential liver damage from conditions like hepatitis, fatty liver disease, or alcohol use.
Lab diagnosis in alcoholic liver diseasePrateek Singh
This document discusses biochemical parameters for diagnosing alcoholic liver disease (ALD). Key tests include liver enzymes AST, ALT, GGT, ALP, and the AST/ALT ratio known as the DeRitis ratio. For ALD patients, the DeRitis ratio is typically greater than 2 compared to 1.1 for normal individuals. Other markers like bilirubin, albumin, globulin ratio, and prothrombin time are also elevated in ALD. Interpretation charts provide guidance on enzyme levels that indicate mild, moderate or severe disease states. The document concludes by emphasizing the DeRitis ratio is the most important biochemical indicator for diagnosing ALD.
This document discusses the clinical evaluation of liver disease through history, examination, and liver function tests. It describes taking a thorough history including risk factors. Physical exam may reveal non-specific findings or signs of liver dysfunction. Liver function tests can detect hepatocellular injury, assess protein synthesis, and evaluate cholestatic disorders through standard lab tests, quantitative tests, blood flow measurements, and radiologic/endoscopic methods. Normal ranges are provided for common liver enzymes and proteins.
This document discusses the use of enzymes as diagnostic tools in clinical chemistry. It provides examples of various enzymes found in different tissues that can be measured in blood and other samples to detect abnormalities and diseases. When concentrations of enzymes are outside normal ranges it can indicate tissue damage or metabolic issues. The document outlines several enzymes and their clinical significance, such as using lactate dehydrogenase to detect heart attacks or alanine transaminase to detect liver damage. It also discusses using isoenzyme patterns and specific assays to distinguish between tissue types when enzyme levels are elevated.
02.01.12(b): Liver Tests - Use and InterpretationOpen.Michigan
This document discusses liver tests and their interpretation. It describes how transaminases like ALT and AST are released from liver cells during injury and can indicate the level of hepatocyte death. Elevated alkaline phosphatase suggests cholestasis or reduced bile flow. Bilirubin levels rise with any impairment of bilirubin excretion from the liver. Certain patterns of liver test abnormalities can suggest the general type of liver disease present.
This document discusses liver function tests and provides normal levels for various liver proteins and enzymes. It also gives equations and examples for calculating levels of alkaline transferase (ALT) and gamma-glutamyl transferase (GGT) from absorption test results. Finally, it provides interpretations of high or normal levels of different proteins and enzymes as indicators of possible liver diseases, biliary obstruction, bone diseases, or alcohol abuse.
Liver function tests (LFT’s) are groups of laboratory blood assays designed to give information about the state of patients liver
They include
Liver enzymes (SGOT, SGPT, ALP, GGT etc.,)
Bilirubin(Direct and indirect)
Albumin
Prothrombin time / INR
The liver is the largest organ in the body
It is located below the diaphragm in the right upper quadrant of the abdominal cavity and extended approximately from the right 5th rib to the lower border of the rib cage.
This document discusses various enzymes used as diagnostic and therapeutic markers. It defines enzymes and their role in biological systems. It describes enzymes like ALT, AST, GGT, LDH, CK, ALP that are used to diagnose conditions like liver disease, myocardial infarction, muscle diseases. It explains how increased or decreased levels of these enzymes can indicate different pathological conditions. It also discusses enzymes like amylase and lipase that are markers for pancreatic disorders. Therapeutic enzymes mentioned include streptokinase, trypsin, asparaginase.
1.Detect presence of liver disease.
2.Distinguish among different types of liver diseases.
3.Estimate the extent of known liver damage.
4.Follow the response of treatment
The document discusses liver function tests and the clinical significance of various enzymes and biomarkers. It is divided into several sections that cover: the functions of the liver; classification of liver function tests into groups that indicate hepatocellular damage or cholestasis; specific enzymes such as ALT, AST, ALP, GGT and their levels in different liver conditions or diseases; clinical cases and how to interpret abnormal enzyme profiles and biomarkers.
This document discusses enzymes and their use in diagnosing various medical conditions. It provides information on several key enzymes, including troponin, CK, LDH, AST, ALT, and acid phosphatase, that are released when tissues are damaged and can indicate conditions like myocardial infarction, muscle damage, liver disease, and prostate cancer. Measurement of elevated or changing levels of these enzymes is important for diagnosing diseases and monitoring their progression or response to treatment.
The document discusses several cases presenting with abnormal liver function tests (LFTs). Case 1 shows a mild isolated transaminitis. Case 2 involves severe hepatocellular injury and mild cholestasis in an alcoholic patient. Case 3 examines LFT patterns in an alcoholic cirrhotic with possible alcoholic hepatitis.
Enzymes in health and diseases discusses various enzymes and their roles in diagnosis and treatment. It describes functional enzymes like lipase and ceruloplasmin that help diagnose liver function. Non-functional enzymes like creatine kinase and lactate dehydrogenase indicate tissue damage when elevated. Enzyme deficiency disorders are also discussed, including examples like galactosemia and phenylketonuria. The roles of specific enzymes are outlined in diagnosing conditions like myocardial infarction, bone diseases, muscle diseases, and prostate cancer. Enzymes can also be used as therapeutic agents to treat diseases.
Liver Function Tests (LFTs) provide information about liver health and disease processes. They include tests of liver transport and metabolism (bilirubin, albumin), hepatocyte injury (aminotransferases, alkaline phosphatase), and biosynthetic function (proteins, ceruloplasmin). Bilirubin and albumin directly assess liver function, while enzymes indicate hepatocyte damage. Elevated enzymes suggest hepatitis. Bilirubin levels distinguish hepatocellular from cholestatic processes. Albumin declines with cirrhosis. LFTs help pharmacists monitor for drug-induced liver injury.
The liver has several important functions including metabolic, excretory, protective, hematological, synthetic, and storage. Liver function tests evaluate the status of the liver and can help diagnose and monitor liver disease. Common tests include albumin, bilirubin, ALT, AST, GGT, ALP, prothrombin time, and total protein levels. Elevations in certain enzymes indicate particular types of liver dysfunction such as viral hepatitis (ALT), alcohol toxicity (GGT), or blockage of the bile ducts (ALP and GGT). Together, liver function tests provide valuable information about liver health and disease.
Kenyatta university. alkalyne phosphataseLando Elvis
1. The document reports on a test to measure alkaline phosphatase (ALP) levels in a serum sample. ALP is an enzyme found in various tissues including the liver and bone. Elevated ALP can indicate liver disease or bone disorders with increased bone cell activity.
2. The test measures the hydrolysis of p-Nitrophenyl phosphate to p-Nitrophenol, which has strong absorbance at 405nm. By measuring the change in absorbance over time, the ALP activity in the sample can be calculated.
3. The results of the test on the given sample show a normal, low level of ALP. This suggests the individual does not have liver disease or a bone
This document summarizes key details about aminotransferases and alkaline phosphatase enzymes. It discusses how aminotransferases like aspartate aminotransferase (AST) and alanine aminotransferase (ALT) catalyze the transfer of amino groups between amino acids and ketoacids, and how their levels are measured to monitor liver damage. AST is more elevated in conditions like hepatitis while ALT is higher in viral hepatitis. Alkaline phosphatase requires magnesium as an activator and exists as isoenzymes in the liver, bone, placenta and intestine that can be differentiated through electrophoresis or immunochemical methods.
Biochemical markers in diagnosis of Liver DIseaseChee Oh
This document discusses liver enzyme tests, what they measure, normal ranges, and their clinical significance in evaluating liver health and disease. It focuses on aminotransferases ALT and AST, which are released when liver cells are damaged and are markers of hepatocellular injury. Elevations in ALT are more specific to the liver, while AST is also found in other tissues. The ratio of AST to ALT and the magnitude of elevation provides clues to different liver diseases.
1. A 65-year-old male presented with fever, abdominal pain, distension, and jaundice for 4 weeks. Imaging showed a diffuse process in the liver. Liver biopsy revealed adenocarcinoma infiltration of the liver.
2. A 58-year-old female with diabetes and elevated liver enzymes was evaluated. She had a history of elevated enzymes attributed to lipid medication years ago. Current labs showed elevated AST and ALT with normal ALP and GGT. She had weight gain and abnormal lipid profile.
3. The first case describes a patient with diffuse liver lesions found to be metastatic adenocarcinoma on biopsy. The second case involves a patient with metabolic risk factors and elevated amin
1. The document discusses alanine aminotransferase (ALAT/ALT), an enzyme that plays important roles in amino acid and carbohydrate metabolism.
2. ALT catalyzes the reversible transfer of amino groups between glutamate and pyruvate, and is important for liver gluconeogenesis and the glucose-alanine cycle.
3. Clinically, ALT levels are measured as a biomarker for liver health, with elevated levels indicating potential liver damage from conditions like hepatitis, fatty liver disease, or alcohol use.
Lab diagnosis in alcoholic liver diseasePrateek Singh
This document discusses biochemical parameters for diagnosing alcoholic liver disease (ALD). Key tests include liver enzymes AST, ALT, GGT, ALP, and the AST/ALT ratio known as the DeRitis ratio. For ALD patients, the DeRitis ratio is typically greater than 2 compared to 1.1 for normal individuals. Other markers like bilirubin, albumin, globulin ratio, and prothrombin time are also elevated in ALD. Interpretation charts provide guidance on enzyme levels that indicate mild, moderate or severe disease states. The document concludes by emphasizing the DeRitis ratio is the most important biochemical indicator for diagnosing ALD.
This document discusses the clinical evaluation of liver disease through history, examination, and liver function tests. It describes taking a thorough history including risk factors. Physical exam may reveal non-specific findings or signs of liver dysfunction. Liver function tests can detect hepatocellular injury, assess protein synthesis, and evaluate cholestatic disorders through standard lab tests, quantitative tests, blood flow measurements, and radiologic/endoscopic methods. Normal ranges are provided for common liver enzymes and proteins.
This document discusses the use of enzymes as diagnostic tools in clinical chemistry. It provides examples of various enzymes found in different tissues that can be measured in blood and other samples to detect abnormalities and diseases. When concentrations of enzymes are outside normal ranges it can indicate tissue damage or metabolic issues. The document outlines several enzymes and their clinical significance, such as using lactate dehydrogenase to detect heart attacks or alanine transaminase to detect liver damage. It also discusses using isoenzyme patterns and specific assays to distinguish between tissue types when enzyme levels are elevated.
02.01.12(b): Liver Tests - Use and InterpretationOpen.Michigan
This document discusses liver tests and their interpretation. It describes how transaminases like ALT and AST are released from liver cells during injury and can indicate the level of hepatocyte death. Elevated alkaline phosphatase suggests cholestasis or reduced bile flow. Bilirubin levels rise with any impairment of bilirubin excretion from the liver. Certain patterns of liver test abnormalities can suggest the general type of liver disease present.
This document discusses liver function tests and provides normal levels for various liver proteins and enzymes. It also gives equations and examples for calculating levels of alkaline transferase (ALT) and gamma-glutamyl transferase (GGT) from absorption test results. Finally, it provides interpretations of high or normal levels of different proteins and enzymes as indicators of possible liver diseases, biliary obstruction, bone diseases, or alcohol abuse.
Liver function tests (LFT’s) are groups of laboratory blood assays designed to give information about the state of patients liver
They include
Liver enzymes (SGOT, SGPT, ALP, GGT etc.,)
Bilirubin(Direct and indirect)
Albumin
Prothrombin time / INR
The liver is the largest organ in the body
It is located below the diaphragm in the right upper quadrant of the abdominal cavity and extended approximately from the right 5th rib to the lower border of the rib cage.
This document discusses various enzymes used as diagnostic and therapeutic markers. It defines enzymes and their role in biological systems. It describes enzymes like ALT, AST, GGT, LDH, CK, ALP that are used to diagnose conditions like liver disease, myocardial infarction, muscle diseases. It explains how increased or decreased levels of these enzymes can indicate different pathological conditions. It also discusses enzymes like amylase and lipase that are markers for pancreatic disorders. Therapeutic enzymes mentioned include streptokinase, trypsin, asparaginase.
1.Detect presence of liver disease.
2.Distinguish among different types of liver diseases.
3.Estimate the extent of known liver damage.
4.Follow the response of treatment
The document discusses liver function tests and the clinical significance of various enzymes and biomarkers. It is divided into several sections that cover: the functions of the liver; classification of liver function tests into groups that indicate hepatocellular damage or cholestasis; specific enzymes such as ALT, AST, ALP, GGT and their levels in different liver conditions or diseases; clinical cases and how to interpret abnormal enzyme profiles and biomarkers.
This document discusses enzymes and their use in diagnosing various medical conditions. It provides information on several key enzymes, including troponin, CK, LDH, AST, ALT, and acid phosphatase, that are released when tissues are damaged and can indicate conditions like myocardial infarction, muscle damage, liver disease, and prostate cancer. Measurement of elevated or changing levels of these enzymes is important for diagnosing diseases and monitoring their progression or response to treatment.
The document discusses several cases presenting with abnormal liver function tests (LFTs). Case 1 shows a mild isolated transaminitis. Case 2 involves severe hepatocellular injury and mild cholestasis in an alcoholic patient. Case 3 examines LFT patterns in an alcoholic cirrhotic with possible alcoholic hepatitis.
Enzymes in health and diseases discusses various enzymes and their roles in diagnosis and treatment. It describes functional enzymes like lipase and ceruloplasmin that help diagnose liver function. Non-functional enzymes like creatine kinase and lactate dehydrogenase indicate tissue damage when elevated. Enzyme deficiency disorders are also discussed, including examples like galactosemia and phenylketonuria. The roles of specific enzymes are outlined in diagnosing conditions like myocardial infarction, bone diseases, muscle diseases, and prostate cancer. Enzymes can also be used as therapeutic agents to treat diseases.
Liver Function Tests (LFTs) provide information about liver health and disease processes. They include tests of liver transport and metabolism (bilirubin, albumin), hepatocyte injury (aminotransferases, alkaline phosphatase), and biosynthetic function (proteins, ceruloplasmin). Bilirubin and albumin directly assess liver function, while enzymes indicate hepatocyte damage. Elevated enzymes suggest hepatitis. Bilirubin levels distinguish hepatocellular from cholestatic processes. Albumin declines with cirrhosis. LFTs help pharmacists monitor for drug-induced liver injury.
The liver has several important functions including metabolic, excretory, protective, hematological, synthetic, and storage. Liver function tests evaluate the status of the liver and can help diagnose and monitor liver disease. Common tests include albumin, bilirubin, ALT, AST, GGT, ALP, prothrombin time, and total protein levels. Elevations in certain enzymes indicate particular types of liver dysfunction such as viral hepatitis (ALT), alcohol toxicity (GGT), or blockage of the bile ducts (ALP and GGT). Together, liver function tests provide valuable information about liver health and disease.
Kenyatta university. alkalyne phosphataseLando Elvis
1. The document reports on a test to measure alkaline phosphatase (ALP) levels in a serum sample. ALP is an enzyme found in various tissues including the liver and bone. Elevated ALP can indicate liver disease or bone disorders with increased bone cell activity.
2. The test measures the hydrolysis of p-Nitrophenyl phosphate to p-Nitrophenol, which has strong absorbance at 405nm. By measuring the change in absorbance over time, the ALP activity in the sample can be calculated.
3. The results of the test on the given sample show a normal, low level of ALP. This suggests the individual does not have liver disease or a bone
The document discusses various liver function tests and their clinical significance. It provides details on the principles, normal ranges and clinical importance of common liver enzymes and tests including ALT, AST, GGT, ALP, total bilirubin, direct and indirect bilirubin, total protein, albumin, prothrombin time and bleeding time. Elevations in these tests can indicate liver damage or other conditions. The tests are useful for screening and assessing liver dysfunction and diseases.
This document provides an overview of liver function tests and their use in diagnosing and monitoring liver diseases. It discusses the main metabolic functions of the liver, including synthesis of proteins and coagulation factors, excretion and detoxification, and bilirubin formation and excretion. Common liver function tests are described that assess hepatocyte damage, synthetic function, and excretory function, including measurements of bilirubin, albumin, aminotransferases, alkaline phosphatase, and gamma-glutamyl transferase. The diagnostic utility and interpretation of elevated results for these tests is explained. An algorithm is provided for using test results to differentiate hepatocellular from cholestatic disease. Two patient case examples are given
This document provides information on various clinical chemistry enzymes and their diagnostic significance. It discusses alkaline phosphatase and acid phosphatase, their tissue sources, reference ranges, and conditions that cause increased or decreased levels. It also summarizes aminotransferases AST and ALT, their role in evaluating liver and heart disorders. Other enzymes discussed include lactate dehydrogenase, creatine kinase and its isoenzymes relevant to heart damage, lipase for diagnosing pancreatitis, and others.
The multiple forms of an enzyme catalyzing the same chemical reaction are called isoenzmyes. They, however, differ in their physical and chemical properties.
Examples: Isozymes of numerous dehydrogenases, and several oxidases, transaminases, phosphatases, transphosphorylases, proteolytic enzymes, aldolases.
Biliary metabolism and physiology of LFT.pptxSourav Panda
This document discusses the analysis and metabolism of bile and liver enzymes. It describes the most commonly tested liver enzymes (ALT, AST, ALP, bilirubin), how they are elevated in different types of liver injury, and their normal ranges. It also explains how these enzymes and bilirubin are involved in bile production and excretion, and how measurements of them can help identify hepatocellular vs cholestatic diseases and liver function.
The document summarizes urea cycle disorders (UCDs), which are caused by genetic mutations that impair the urea cycle - a pathway in the liver that detoxifies ammonia. The key points are:
1) UCDs can range from severe neonatal presentation with hyperammonemia and coma to late-onset episodic symptoms.
2) Diagnosis involves measuring elevated blood ammonia and amino acid levels. Enzyme analysis or DNA testing can confirm the specific UCD.
3) Treatment focuses on removing ammonia via medications like sodium phenylacetate-sodium benzoate, supplying essential precursors like arginine, and preventing protein intake and catabolism. Vig
The document discusses liver function tests and the clinical significance of various enzymes and biomarkers. It is divided into several sections that cover: the functions of the liver; classification of liver function tests into groups that indicate hepatocellular damage or cholestasis; specific enzymes such as ALT, AST, ALP, GGT and their levels in different liver conditions or diseases; clinical cases and how to interpret abnormal enzyme profiles and biomarkers.
The document presents information on estimating alkaline phosphatase levels in serum, including that alkaline phosphatase is an enzyme responsible for dephosphorylation, it is commonly tested to evaluate liver and bone function, and the test involves combining serum with reagents to produce a color change that corresponds to alkaline phosphatase levels.
This document discusses various biomarkers used in the diagnosis of liver disease. It describes how bile salts facilitate fat absorption and are excreted in urine during cholestasis. Primary and secondary bile salts are produced in the liver and intestines. Increased renal excretion of bile salts occurs during cholestasis. Liver enzymes like ALT, AST, ALP, GGT and 5-nucleotidase reflect hepatocyte damage and cholestasis. Elevated ALT and AST indicate hepatocellular injury. Increased ALP, GGT and 5-nucleotidase suggest cholestasis. Prothrombin time is prolonged in liver dysfunction due to decreased synthesis of clotting factors. Albumin and globulin
This document discusses various liver biochemical tests and what they indicate about liver health and function. It covers tests of bilirubin, aminotransferases, alkaline phosphatase, synthetic functions, and fibrosis markers. Elevations in these tests can suggest conditions like viral hepatitis, alcoholic liver disease, cirrhosis, and others. No single test fully assesses liver function, so a battery of tests is needed to evaluate the liver and distinguish between different disease types and severities.
Liver function tests (LFTs) are a group of blood tests that detect inflammation and damage to the liver.
They can also check how well the liver is working.
Many tests can be performed to check liver abnormalities are :
Serum bilirubin
Urine bilirubin
Serum alanine transaminase (ALT)
Serum aspartate transaminase (AST)
Serum alkaline phosphatase (ALP)
Serum total protein and albumin
This document discusses serum enzymes that can indicate liver disease states. It outlines enzymes that reflect hepatocyte damage like ALT and AST, as well as enzymes that indicate cholestasis such as alkaline phosphatase, GGT, and 5'-nucleotidase. ALT and AST are more specific to liver injury than other tissues. Alkaline phosphatase is also elevated in bone diseases. GGT and 5'-nucleotidase are more sensitive markers of cholestasis than alkaline phosphatase. The document also presents two case studies, one with signs of alcoholic liver disease and another with possible liver metastases from lung cancer.
CLINICAL_BIOCHEMISTRY ENZYMES AND THEIR FUNCTION TESTS IN THE ORGANSJamesMwaura15
1. Liver enzymes help evaluate liver disorders by indicating damage to liver cells (hepatocytes) or cholestasis. Enzymes like AST, ALT reflect hepatocyte injury while ALP, GGT, 5'NT reflect cholestasis.
2. AST and ALT are aminotransferases that catalyze transfer reactions and are released from hepatocytes during injury. ALP is a hydrolase involved in membrane transport. GGT and 5'NT also indicate cholestasis.
3. Abnormal levels of these enzymes can indicate conditions like viral or drug-induced hepatitis (AST, ALT), biliary tract diseases (ALP, GGT), or space-occupying lesions
The document discusses liver function tests (LFTs). It begins by providing an overview of liver anatomy and physiology. It then discusses the various functions of the liver including metabolic, excretory, protective, hematological, and storage functions. The goals of LFTs are outlined as detecting liver disease, distinguishing disease types, and monitoring treatment response. Common LFTs are described such as bilirubin, alkaline phosphatase, GGT, AST, ALT, albumin, and prothrombin time. Elevations in these enzymes and proteins can indicate liver damage or disease. Causes and interpretations of abnormal LFT results are provided.
This document discusses various biochemical and radiological tests used to evaluate renal function and diagnose renal disease. It describes tests that measure glomerular filtration rate (GFR) like creatinine clearance, urea clearance, and inulin clearance. It also discusses tubular function tests like urine analysis, concentration tests, and acid load tests. Biomarkers of renal injury like kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and interleukin-18 are also summarized. Radiological investigations like ultrasound, CT, MRI, renal scans, biopsy and cystoscopy are also mentioned.
Hepatic encephalopathy is a syndrome seen in patients with cirrhosis characterized by personality changes, intellectual impairment, and depressed consciousness caused by liver dysfunction and diversion of blood flow. The main mechanism is believed to be increased levels of ammonia, which is normally processed by the liver, having neurotoxic effects in the brain. Grades of hepatic encephalopathy are classified based on symptoms ranging from mild confusion to coma. Treatment focuses on reducing ammonia through lactulose or antibiotics like rifaximin, with lactulose being the first-line treatment.
The document discusses liver function tests and their use in evaluating liver health and disease. It covers the metabolic, excretory, synthetic, detoxification and storage functions of the liver. Liver function tests are classified based on the liver's excretory, detoxification, and synthetic functions. Enzymes like ALT, AST, GGT, ALP, and bilirubin are discussed in the context of diagnosing different types of liver disease and jaundice. The document also discusses pancreatic function tests and enzymes like amylase and lipase that are indicators of pancreatic health and diseases like pancreatitis.
Similar to Serum Alkaline Phosphatase Activity And Its Iso Enzymes In (20)
Serum Alkaline Phosphatase Activity And Its Iso Enzymes In
1. SERUM ALKALINE PHOSPHATASE ACTIVITY AND
ITS ISO-ENZYMES IN INFLAMMATORY
SYNDROMES
Aurelian Udristioiu, Emergency County
Hospital Targu Jiu, Clinical Laboratory, Romania.
Fax: 40253210432; Phone; 40723621414; E-
mail: < aurelianu2007@yahoo.com >
2. Different biochemical forms of alkaline phosphatase (ALP) are
called iso-enzymes.
Neutrophils may be an important source of increased serum
alkaline phosphatase, named neutrophil alkaline phosphatase
(NAP). NAP in Leukemoid Reactions must be distinguished from
other types of serum alkaline phosphatase enzyme, such as bone
alkaline phosphatase (BAP) and bile alkaline phosphatase (bile-AP),
increased in pathological conditions.
The present study describes the indirect evidence that high levels
of ALP in serum may explain the high level of serum alkaline
phosphatase by increasing BAP and NAP in patients with benign
and malignant diseases of bone and inflammatory syndromes.
In the liver, hepatic alkaline phosphatase (HAP) is found on the
edges of cells that join to form bile ducts that drain bile from the liver
into the intestine, where it is necessary to help digest fats in the diet.
HAP is increased in acute and chronic liver diseases.
When a person has high levels of serum ALP and the doctor is
not sure why, for to discovery of causes, he can prescribes
determination Semi-Quantitative Cyto-Chemical NAP.
3.
4. • Total Serum ALP
• Normal values of serum for total ALP there are different in
function of ages: 120-700 U/L for children 1-15 years, 90-190U/L for
adult males and 85-165 U/L for adult females.
• Higher values, past limits of laboratory references, meet in
pathology of liver as acute and chronic hepatitis, hepatic cirrhosis,
biliary obstruction and stasis after 24 hours, malign processes,
colangists, benign and malign diseases of bones,
hyperparathyroidism, duodenal ulcer and in metastases.
• The children have higher ALP because of their bones which are
growing. ALP is often very high during the “growth spurt" which
occurs at different ages in males and females, eating some drugs,
specially used in treat psychiatric problems.
5. Serum iso-enzymes ALP from Liver
• When a person has evidence of liver disease, very high ALP
level can tell to doctor that the person `s bile ducts are somehow
blocked. Often ALP is high to persons which have a cancer that has
spread to liver or bone and doctors can further testing to see if this
has happened.
• If other liver tests, such total bilirubin (TBIL), aspartate amino-
transferase (AST), or alanine - amino-trasferase (ALT) are also
high, usually the ALP is coming from the liver.
• In this case and enzyme gamma-glutamil-transferase (GGT), that
is secreted in the same place with HAP, is high. HAP from liver
represents 60% amount from total serum ALP.
6. • -Bile ALP
• When the bile ducts are blocked, usually by gallstone or by
cancer, ALP and bilirubin may be increased more than AST or ALT.
In the hepatitis, ALP usually much less elevated than AST and ALT.
Also Bile-ALP is increased in cole-stasis, colangio-carcinoma,
primary tumor of liver and metastases of liver.
• -Placentary ALP
• The ALP levels can be increased in Pregnancy of three trimesters
and also in placentary malignancy, (ALP Reagan), by high level
placentary ALP type.
• - Like placentary ALP, which can measured after warm of serum to
56 C*grade time of 10 minutes, is increased in more forms of
cancers.
• The intestinal Izo-enzyme ALP
• Intestinal ALP is increased in cirrhosis and blood group O or B
segregated .The “intestinal” form of ALP is determined by its
phenylalanine sensitivity.
• -Duodenal ALP has normal value until 90 U/L. This type of ALP is
higher in cirrhosis of liver, intra-liver colestasis, enteritis and chronic
hemo-dialysis.
7. • Bone Alkaline Phosphatase in Serum (BAP).
• BAP is a glycoprotein that is found on the surface of osteoblast
cells. BAP has been shown to be a sensitive and reliable indicator of
bone metabolism. If calcium and phosphate measurements are
abnormal, usually the ALP is confirmed as originally from the bones
in some bone diseases such as a disorder called Paget`s disease or
in cancer with bone metastasis.
Method of Measurements of BAP
• By an immune-enzymatic assay is utilized a mouse monoclonal
antibody specific to BAP, paramagnetic particles coated with
antibodies and complex Ag -Ac is measured with illuminometers.
Normal values of BAP there are until 90 U/L, (30% of total ALP)
•
8. • Current Methods of Measurement of ALP from serum:
• 1. Cinetic-Colorimetric Method has as principle the activity of
enzyme ALP in basic medium which p-nitrophenyl phosphate
molecules. Finally results p-nitrophenol and an inorganic phosphate
molecule. It use only fresh serum or plasma, delivered on heparin
without hemolysis.
• Ions of magnesium accelerate activity of enzyme. Increased
absorbance per units of time (yellow intense color) is proportionally
with activity of alkaline phosphatase to 405 nanometers wavelength.
For the type of Photometers with filters must accomplished the
calibrations using a Standard.
9. • 2. The dry Chemistry uses the “Vitros ALKP Slide which is a
multilayered analytical element coated on a polyester support.
• The p-nitrophenol which absorbs light of wavelengths in the region
of 400 nm, diffuses into be underling layer of Vitros slide and it is
monitored by reflectance of spectrophotometers. The rate of change
in reflection density is converted to enzyme activity.
•
• Reference interval of manufactures comprises the central 95% of
results from an interval study of 273 apparently healthy, adults from
a working population, (154 females and 119 males) and has the
normal range 36-126 U/L.ALP.
• Some metabolic components and Drugs that have significant light
absorbance in the region 400 nanometers can cause a special
interference (bilirubin, methotrexate, nitrofurantoin. A compilation of
this information is available in the literature.
10. • 3. . Serum NAP ( neutrophil alkaline phosphatase) activity in serum can
be measured by the method of Japanese Society of Clinical Chemistry, in
which ALP its-enzymes are separated electrophoretically with Titan 3
supporting media (Helena Laboratories).
• Neutrophil Alkaline Phophatase (NAP), an enzyme closely associated
with neutrophil granules, is ready measured by a quantitative chemical
method or semi-quantitative histo-chemical method.
• NAP appears to be restrictive in bands of segmented neutrophil
granulocytes. Its delivery from lysozome in cytoplasm is controlled by 2
genes of 21 chromosomes.
• On colored smears, in microscopic field, sites with enzymatic activity
NAP will appear as dark-blue grants or black grants in cytoplasm of
granulocytes.
• The interpret of reaction will be made in function of score to 100
segmented granulocytes after amounts and intensity of colored grants in
scale 1-4.
• The score of Leukocyte Alkaline Phosphatase will be the product
between number of counted cells and values of percent (%).
Normal score are 60-100 values.
11. • Technical Method of Laboratory:
• Kit SIGMA:
• -Sample-Fixation with solution alcohol-phenol 9/1
concentration,
• -Incubation with glicero-phosphate substrate,
• -Ad nitrate of cobalt 2% concentration,
• -Wash slide,
• -Ad solution sulfur ammonium acid Calcium black
sulfur,
• -Coloration with May Grunwald Giemsa.
12.
13. • DISCUSSIONS;
• In microscopy field, on smear, granulocytes display predominant
toxic granulations, Dohle bodies, and in serum there is elevated
NAP.
• -In mature granulocytes from CML, NAP decreases until “0”, and
than appears after treatment with chemotherapy.
• -Permits the differentiation, in case of leukocytosis, between CML,
where NAP is absent and PV where NAP is increased past normal
interval.
• -Permits the differentiation of secondary poliglobuly, with NAP
decreased or lower score with PV when NAP is very increased.
• -Can to differentiate an Acute Leukemia un-treated with cortyzol
drugs:
• A) In Mieloblastic Acute Leukemia, in mature neutrophiles NAP zero
or lowly.
• B) In Limphoblastic Acute Leukemia, in mature neutrophiles NAP is
decreasd.
• C) In Hanry Cells Leukemia, with severe neutropenia, NAP is very
high.
14. • In Non-Hodgkin Acute Lymphoma NAP is decreased but in
Hodgkin Lymphoma has very high score.
• To children, the score LAP is increased in CML. In the
Threesomya 21 –Mongolism, NAP is increased because of surplus
of chromosomes.
• The enzyme NAP must be examined only in segmented and un-
segmented neutrophils and eosinophils. The basophil is negatives
NAP and not must be counted in the level of score ALP.
• The enzyme NAP permits the physical-pathological
understanding of neutrophils which though in microscopy field
appear normally but these have a modified chemical content and
emphasis the functionality of leukocytes.
15.
16.
17. • CONCLUSION
•
• -Direct evidence of iso-enzymes ALP is can be done by
the biochemical and immunochemical properties of ALP,
especially in the serum to patients with high numbers of
leukocytes and we have proposed to assess laboratory
results for to help clinicians in correct decisions to
hospitalized patients, especially in the Point-of-Care
Department.
• - We consider that this our objective must be in the
attentions of all Laboratories.